SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)							3 Months Ended	12 Months Ended
	Apr. 01, 2025	Nov. 12, 2024	Oct. 01, 2024	Sep. 23, 2024	Sep. 17, 2024	Sep. 16, 2024	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Jul. 31, 2023	May 10, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares authorized											120,000,000
Common stock, shares issued							100,000,000	100,000,000	100,000,000		100,000,000
Common stock, par value							$ 0.001	$ 0.001	$ 0.001		$ 0.001
Preferred stock, shares authorized							20,000,000	20,000,000	20,000,000		20,000,000
Preferred stock par value							$ 0.001	$ 0.001	$ 0.001		$ 0.001
Common stock, shares issued							13,736,597	13,736,597	10,562,640
Common stock, shares outstanding							13,736,597	13,736,597	10,562,640
Preferred stock, shares outstanding							0	0	0
Settlement of dispute									228,284
Fair value of shares				$ 100,000					$ 912,000
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares								10,000
Gross proceeds proceeds from issuance initial public offering								$ 5,524,000
Reclassification of deferred offering costs to shareholders equity								$ 872,000
Issuance of common shares upon conversion of accounts payable, shares								514,940
Conversion of accounts payable to shareholders equity								$ 1,789,000
Issunace of shares		$ 900,000						4,652,000
Aggregate fair value of the common stock							$ 500,000	500,000
Stock issued value								1,878,000
Stock compensation for the fair value vesting restricted common stock, value								93,000
Proceeds from notes payable								142,000
Stock compensation-related expense for fair value vesting of restricted common stock								$ 218,000
Convertible note payable												$ 250,000
Dividend rate								0.00%
Fair value of warrant								$ 29,000
Convertible Notes Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Convertible note payable									$ 743,000			$ 675,000
2023 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares									0
Common stock reserved for future issuance										1,650,000
Restricted units issued								172,000
Shares available for grant							1,478,000	1,478,000
Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested								68,341
Granted shares								240,341
Stock compensation-related expense for fair value vesting of restricted common stock								$ 218,000
Fair value of unamortized compensation							$ 314,000	314,000
Chief Financial Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of accounts payable								$ 172,000
Conversion of shares								51,610
Conversion price per share percentage								83.00%
Fair value accounts payable							206,000	$ 206,000
Financing cost								34,000
Amount owed							$ 0	0
Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of shares								$ 42,000
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares								32,071
Three Independent Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Annual cash compensation								$ 50,000
Chair of the Audit Committee [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Annual cash compensation								$ 10,000
Cedars-Sinai Medical Center [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price							$ 2.40	$ 2.40
Conversion of accounts payable								$ 750,000
Conversion of shares								312,500
Conversion price per share percentage								60.00%
Fair value accounts payable							$ 1,250,000	$ 1,250,000
Financing cost								$ 500,000
Another Cedars Sinai Medical Center [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price							$ 1.33	$ 1.33
Conversion of accounts payable								$ 200,000
Conversion of shares								150,830
Conversion price per share percentage								60.00%
Fair value accounts payable							$ 333,000	$ 333,000
Financing cost								$ 133,000
Cross Current Capital LLC [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issunace of shares	$ 500,000
Cross Current Capital LLC [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares			367,647
Issunace of shares			$ 500,000
Helena Global Investment Opportunities I LTD [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares		670,641
Issunace of shares		$ 900,000
Stock issued value		$ 1,378,000
Strategic Advisory Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested								0
Fair value vesting of restricted common stock.								$ 29,000
Strategic Advisory Agreement [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares				50,000
Four Officers Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of shares								$ 226,000
Number of shares vested								0
Four Officers Agreement [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares								92,000
Three Officers Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of shares								$ 89,000
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares								36,270
Stock compensation for the fair value vesting restricted common stock, value								$ 89,000
Proceeds from notes payable								142,000
Director Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of shares								74,000
Fair value vesting of restricted common stock.								$ 7,000
Director Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested								0
IPO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares					1,550,000
Share price					$ 4.00
Gross proceeds proceeds from issuance initial public offering						$ 6,200,000
Net proceeds proceeds from issuance initial public offering					$ 5,524,000
Reclassification of deferred offering costs to shareholders equity								$ 872,000
Additional shares issued					232,500
IPO [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Granted shares								30,000
IPO [Member] | Underwrinting Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares					108,500
Warrants outstanding, weighted average exercise price					$ 4.80
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares outstanding							0	0	0
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares								1,550,000
Additional shares issued								1,664
Issuance of common shares upon conversion of accounts payable, shares								514,940
Conversion of accounts payable to shareholders equity
Issunace of shares								2,000
Stock issued value								$ 1,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants outstanding, weighted average exercise price					$ 4.80		$ 4.29	$ 4.29
Purchase of warrants					108,500
Warrants outstanding, outstanding number of options, shares							278,188	278,188	150,000			180,000
Warrant expiration								9 months 7 days
Warrant shares outstanding, intrinsic value							$ 0	$ 0
Warrant [Member] | Convertible Notes Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants outstanding, weighted average exercise price												$ 4.17
Purchase of warrants												150,000
Warrant One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price					$ 2.46
Warrants outstanding, weighted average exercise price					$ 2.40
Warrants outstanding, outstanding number of options, shares					19,688
Expected term					2 years 6 months
Volatility					100.00%
Dividend rate					0.00%
Risk free interest rate					3.49%
Fair value of warrant							$ 29,000
Warrant expiration					5 years